5" February, 2016 10 cee The Managor, Listing Department, National Stock Exchange of India Ltd, ‘ SG To, Department of Corporate Services Bombay Stock Exchange Ltd Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai — 400 001, Inge Plaza’, C-1, Block Bandra-Kurla Complex, Bandra (E), Mumbai — 400 051 Ref. : (i) Symbol - DISHMAN Ref.: Scrip Code No. : 532526 (ii) Series ~ EQ At the said Board Meeting the said Unaudited Results were adopted and approved, Which are attached herewith, Wie itv also uploaded the results on the Company's website at vshmanaroup.com and on the website of the stock exchanges at Wwuwbseindia.com ‘and www.nseingia.com, Kindly take this on your record, Thanking you Yours faithfully, For Dishman Pharmaceuticals and Chemicals Limited Tushar D. Shah Company Secretary Encl: As above Dishman Pharmacouticals and Chemicals Limited Registered Office: Bhodr-Ro| Chombers, Swasik Cross Roods, Nevrangpura, Ahmedabad - 380 008 Jn, Tol: +91 (0) 79 26443083 / 26445807 Fox: +91 (0) 79 26420198 Email: dishman@dishmangroup.com Web: www.dishmangroup.com Government Recognised Export House CIN NO 124230611 983LCo0sa29 NSFor Stock Exchange DISHMAN PHARMACEUTICALS AND CHEMICALS LIMITED emateezttG963°LC006529 EmallD clshman@xiehmangroupcom Web www dishmangroupcom Parl eeacnambers,Snastk Cross Roads, Navrangpure,Almesubes sap e06 Pree 079-26443063 Fax No: 078-264201 Patt: Statoment of Standalone Contos UnauitadResus or Qatar an ane ge 31122018 (Rupees in Lacs) ‘STANDALONE, Se PARTICULARS sa | rT Pecing [For he [rar ine Won | Far Coreaponlng] Fare aSV GASP No fended Gorresponding Jended —— 31-| Nine Months ended | Stoszoie 31122015, Quarter ended 122016 31422014 3.t22014 asucited rcited Unaudited nucited rauated aoa 1 |itsome Fram Operations >) Net salesincome fom oparatons Nato erase Gy TiBseaE STE Tease SERETS VI Tee 2) Other Operating hare rE ne ae Taare Tass Tara otal income from operations (he 7957.98 Tans. 7258.09 Terisa8 arias BA. 7 [expenses 2) Cost of materia conse T6555 Tae Sree EeaaT Em Foes 2) Purchase of sock ade 353.10 5 088 389.10 16314 2.50595 >) Gtanges in inventes of faahod goads WOT co Tai 64 Tatas 78834) 225973) rooress ara stockin rae [| Empiovee bene expense was Te s7 Tae areas Tae ET, Je) Depreciation and emerisnten pane 7105.88 7,089.08 1197.50 3324.00 33597. aaisze I) Other Expanaare Zo1ee7 1267.89 95402 3.40.50 ‘570078, 73155 Hota expenses 373470 B0e38 132.65 EISzET 2550445 iar ' [Profit (Loss) rom Operations blore Oar income, ‘3.20828 198827 302546 ‘BORA 7.08740 Toa04.se [Reence costs and exceptional kems (1-2) omar Basa aaa wae Si0057 Sora oes ' [Prot (Loss) from ondary activites bafora Trance Saas 6.9068 seaa7e Tat7248 WsTsT 79887, costs and exceptional toms (34), S |Finanea costs Tasos T7e87 ae Eo EE Coe 7 [Profi\Loss) from ordinary aciviles afar Rance Coos 2018.39 ‘267 15718 3382.99 ‘8.28287 70,382.59 but betore exceptional items (56) 6 [Bcceptonat tems 5 5 5 = 5 : * [Profits] trom Ordinary Actos before ax 7a) 2a BURT Tar. Dery SRL Wa “0 [Fax expanse: ors Tes ware Toe ERC TRAE 1 [Net Protos om Onanary Acts aaa Ty 7611.05 ‘39056 08 539651 3.50005 ‘e785 i ey : E : 5 5 15 Net Protoss) for tho peiog (7-42) Teas Tae wae 38637 3005 Taras 1 [income om AsSooaas 5 5 : F = = : : 35 [Minor erst F 3 F : + T ‘16 [Net Profit/ (Loss) afer taxes, minoriy HiSveat aad Tas ae eae 83063 DO Sars share of profits (oss) of associates (12¢44015)| [Pease ay Sirs Capt acs Vans RS par For Stock Exchange feauity chore) 7 Tarae Tae Tae Taso TEBE Tear ‘Exciang Revaluation Rasen 65 pat GTS [sheet prevcus accountng year 1 [Bei nd Died EPS (itor sar Brana ay RET lorRs. 2 each) I) Basic EPs (Rotana li Distes EPS (Not annaateog) 300 aoa Too 7 7 200 a4 00 723 [See accompanying notes tthe ance roa a3 apeFor Stock Exchange ‘7 [Paid-up Eauty Shave Caplal (race Vatu RSH par fecuty share) Tas Taso Tas TaaeT Taso Taise 1 [Reseves Excng Revaluation Rasoves 3s Pav BOSSE Peet of previous accountng year TEE de lores. 2 each) Basie EPS (Wot anmuatesay aa 17 oo ry Tans 0.6. J Dived EPS (Wot ennualsecy 302 a2 298 15.02. [See socompanyng notes to the Rana TSAFor Stock Exchange [__[Beaiment wae ‘Revenue, Result and Capital Employed Ea PARTIES Fortean Fay The Pace | ori —| Farinas Farconsaamy | Fre vow cma No| ended ‘Quarter ended Corresponding ended 31-| Nine Months ended 31-03-2015 seszas | “oanaowe” | Gtaerenced "*Saanis | Noman a seaaone a Tot [Samer oa oe a aaa ms] — saa aE] — rasa [bone tate a san] — seme aie ais Total 38,247 42, 37,366.45 38,584.34 495,647.50 113,972.67 156,034.98. ess aaa Roe ‘ : Wess ica Tos Gos ae Tew sess] —Ter| —aaarear| —ara 7 [Seanent Resi (rattcoey boon aaa rem ach pms lorcnmasr ware oe sao} earn ar Tae ly onent Ta a ora] — ars Tomes THE {Yetat 6,208.76 6530.37 aoa. 22,657.73 15,808.40 16,199.54, ss tea Sat zemar| Heep Tir Taber [9 erica Sanne ao oR aay an3s| Tata} — Tass cr tal ProStar Tae Ta sae] reas Tas Ta 5 [etl Enpyed Segnan Sava Sopnoa TARTS ToT 2 {0} Otrers $6,264.69 88,083.91 82,507.25 96,254.69 82,507.25. 2455157 foun oan a zane] sae se Satta [rotar 234019 221,437.95, 213,860.98 223,460.19 213,860.98 217,047.61 7 es Fre Con a Saas SS fs/ a ce: Anmesatea (sucoana [Date: Sth February, 2016 a AMEDABAD S| Lor3. 4 ‘The Financial results have been reviewed by the Audit Committee and taken on record by the Board of Directors at their ‘meetings held on 5” February, 2016 ~eint Statutory Aucitors have caried out a Limited review” ofthe standalone financial result of the Company for the quarter ‘ended 31% December, 2015, “The figures have been re-grouped, re-cast and re-arranged wherever considered necessary; As per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2016, the Company has opted to Publish only consolidated financial results. The stand-alone financial resuits are available for perusal on the Company's ‘website as well as on the stock exchanges’ websites as stated below: wow dishmangroup.com, www.bseindia.com, and www.nseindia.com. ‘As per Accounting Standard (AS) 17 - “Segment Reporting’, segment information has been provided in Consolidated Financial Result ‘The business segments of the Company comprise the followings: ‘Segment. Description of the activity [GRAMS Contract Research and Manufacturing Segment under Tong term supply ‘agreements, OTHERS Bulk Drugs, Intermediates, Quats, Specially Chemicals and Traded Goods Consolidated financial results comprise the results of the parent Company, Dishman Pharmaceuticals and Chemicals Limited and its subsidiaries viz. Dishman Europe Limited., Dishman USA Inc., Dishman Intemational Trading (Shanghai) Co. Lid, Dishman Switzerland Limited, Dishman Pharma Solutions AG, Switzerland, CARBOGEN AMCIS (Shanghai) Co. Ltd. {formerly -known-as: Dishman Pharmaceuticals & Chemicals (Shanghai) Co. Ltd.J, Shanghai Yigian Internatiorial Trade Co., Lid, Innovative Ozone Services Inc. (1038), Dishman Netherlands B. V. (formerly known as “Pharma Syn B. V."), Cohecie Fine Chemicals B.V. (formerly known as “Dishman Holland B.V."), Carbogen Amcis Ltd. (formerly known as “Synprotec DCR Ltd"), CARBOGEN AMCIS AG, Switzeriand, Carbogen Amecis (India) Limited, Dishman Australasia Pty. Ltd., Dishman Care Ltd’ CARBOGEN AMCIS SAS, Dishman Middle East (FZE), Dishman Japan Limited, one joint venture Company, namely Schutz Dishman Biotech Ltd.(22.33% holding by Dishman), and one associate company namely, Bhadr-Raj Holdings Pvt. Ltd, (40% holding by Dishman) as per relevant Accounting Standards. Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, the aforesaid financial Result may be accessed on the Company's website at www.dishmangroup.com and may also be accessed at the website of the Stock Exchanges where the shares of the Company are listed at \www.bseindia.com and www.nseindia.com. On behalf of the Board of Directors pit Vyas ~~ Managing Director & CFO@dishman To, Department of Corporate Services Bombay Stock Exchange Ltd. Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 5” February, 2016 To, The Manager, Listing Department, National Stock Exchange of India Ltd, “Exchange Plaza”, C-1, Block G, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051, Ref.: (I) Symbol - DISHMAN (il) Series - EQ Ref.: Scrip Code No. Sub.: Submission of Statutory Auditors’ d Review Report - Regulation 33 Dear Sir, As per the requirement of Regulation 33 SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we submit herewith a copy of Statutory Auditors’ Limited Review Report dated 5" February, 2016 signed by Ws. V. D. Shukla & Co, and Ms. Haribhakti & Co. LLP, Chartered Accountants, Joint Statutory Auditors of the ‘Company in respect of the Unaudited Financial Results of the Company for the quarter ended 31 December, 2016. ‘We would like to inform you that the above referred Limited Review Report was placed before the Board. Kindly take the same on your record and oblige. Thanking you, Yours faithfully, For Dishman Pharmaceuticals and Chemicals Limited Ge. Tushar D, Shah Company Secretary Encl.: As above Dishman Pharmaceuticals and Chemicals Limited Registered Office: Bhodr-Roj Chambers, Swostk Cross Roads, Navrangpure, Ahmedabad ~ 380 009 Indi. Tel: +91 (0) 79 26443053 / 26445807 Fox: +91 (0) 79 26420198 S Email: dishman@dishmangroup.com Web: www.dishmangroup.com Government Recognised Export House. CIN NO 1242306s1989PLC006329Limited Review Report Review Report to The Board of Directors Dishman Pharmaceuticals and Chemicals Limited 1. We have reviewed the accompanying Statement of Unaudited Financial Results of Dishman Pharmaceuticals and Chemicals Limited (‘the Company’) for the Quarter ended December 31, 2015 ("the Statement”). This Statement is the responsibility of the Company's Management and has been approved by the Board of Directors. Our responsibility is to issue a report on the Statement based on our review. 2. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” 'ssued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement free of material misstatement. A review is limited primarily to inquiries of Company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion,3. Based on our review conducted as above, nothing has come to our attention that causes us to Believe that the accompanying Statement, prepared in accordance with applicable accounting Standards as specified under Section 133 of the Companies Act, 2013 read with Rule 7 of the Companies (Account) Rules, 2014 and other recognised accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Haribhakti & Co. LLP For V. D. Shukla & Co. Chartered Accountants Chartered Accountants ICAI Firm Registration No.103523W ICAI Firm Registration No. 110240W “Bartar Mite as Bhavik L. Shah Vimal D. Shukla Partner Proprietor Membership No. 122071 Membership No. 036416 Place: Ahmedabad Date: February 05, 2016DISHMAN PHARIEACEUTICALS AND CHEMICALS LIMITED (Ge: (282306.19830LC006%29 Ema ID: dshman®dlshimangroup.com Wb: wiw.cishmangroup.com ‘hac Ro] Chamber, Swastk Gross Ross, Marangpur, Abmodabad80000Phane No 70t044000 Pox No: OT2:26420186: Patt: Statement of Standslone UnaudedResul for Quran Nine Monthe Enea st este (Rupees nts) SNORE Forte | Forte Ls Foethe Fortine | comssponding| Forte Yeor a ann arcrenans| Presta | coneapenang | Pot MMe, aresront t= uns Saiszao’ | xara} Guar ead [Mies Mine ots | ned seasanis. | ottzanne ae raed |“ Unnaed |“ Uneuaied | Unaaaieg | tracted | Ra eyReteisincene Fon cwalona Neto | —TTREA2] —aTREBe| —TERESa]} —sasea7o] —arraase} ar lee amy fs) oer Opaatig reas aatse| ar Sai | rare] — see] a [ott nome rom opratans A esa7s6| Foes. s3| Tz ish09| se rine | —searcas | — aes lj cost of aa cae OaEIO| “aoe 6| “sree | mero | — eas] ae [Purchase of sk ace Sexo : a9] sa. rease[ ase [ogee hire ‘ose | eas ay) aaa] Tat at] — 0838] — en) [a Eraigjee Donors ae Tas | rrr] — rey SEE -) Deeds and anceston Sais 7.i0sas | 16086] 170 amaze ober epee ‘biker | teres | —— Tae 731 otal expenses srsaro| — gona | —a anes Eun 7 JPrott Lose) ran Opinions Detar Other | anes | -—tsesat] asa oaDks Income, tance costs and exceptional tomo ley 7 onernane Ba] ase | — amar | ara} ar [eet (Loss) Wom rina eave bofora]|——Taaastz|_—gaane | ance | aa trzan| Tere? |} tesa nance cost and exceptional teme (et), Coo ROE | peer | aso | ares |] — are | a 7 roicoss) om oan avi er z01039| —s,isaer} irae] —asuaso] —— sear] tas fnance coats bt befor exceptional Kom fee 7 porate - 2 [ross ro OTS RET ae Saar ——aasite| —anezaa} sana] fc) 7 ex expanae rE| Te ae] eae] ae] ae 7 Pet Prottose) om Ordinary Raos Tatts] 39085 wakas | —eatest | ——azenas | — saunas oi), 72 | Eavorinay tore GALT T CRT 7 zi - - 73 at PretatLser er Taos] ae a 7 [as os Rano 5 Fi Fi 7 ay rt. I = = 7 filet rot (one Sar ae, wna Tania] — aaa areas a terest nd share of rot os) of lesson (301409 JP Egy Share Coal Fas Vabn et TSBs] Tae] TREE} TES] TS] ls 2 por at rae) "i [Resaves cg Reva RSENS 5 : 5 EvETT pe balance set of previous acai your [base and DaSTEMS ele wor 5 Fi 5 i i lessor toms) (of sey [Sasi |F 5 Not stead 2 TH cy 7 30 Tz Load EPS (Not arruaiod) 200 ao 100 Tas 230 73 [Se axoriparyng nts fe areal Tare Pics: Anmedated [Dste: tn February. 2006Notes: Place: Ahmedabad Dat ‘meetings held on 5" February, 2016 ~oint Statutory Auditors have caried out a“Linited review’ of the standalone financial result of the Company for the quarter ended 31" December, 2015 ‘The figures have been re-grouped, re-cast and re-arranged wherever considered necessary; As per Reguiation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2016, the Company has opted to publish only consolidated financial resuls. The stand-alone financial results are availtle tar perusal on the Company's ‘website as well as on the stock exchanges’ websites as stated below. sewn cishmangroup.com, www bseindia.com, and www.nseindia.com, ‘As Per Accounting Standard (AS) 17 - “Segment Reporting’, segment information has been Provided in Consolidated Financial Result. Fussiant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, the aforesaid financial He atone accessed on the Company's website at waw.dishmangroup.com and thay as Ce ‘accessed at the website of the Stock Exchanges where the shares of the Company are listed al wawv-bselndia,com anc amye ecco com. February, 2016